Evidence map›Paper›PMID 34307185›Full record

ArticleFrontiers in cellular and infection microbiology2021

Presence of L1014F Knockdown-Resistance Mutation in

Hongying Zhang, Mingqiang Li, Ruixiang Tan, Changsheng Deng, Bo Huang, Zhibin Wu, Shaoqing Zheng, Wenfeng Guo, Fei Tuo, Yueming Yuan and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Hongying ZhangArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Mingqiang LiArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Ruixiang TanArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Changsheng DengArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Bo HuangScience and Technology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhibin WuThe Ministry of Health, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Shaoqing ZhengScience and Technology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Wenfeng GuoArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Fei TuoArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yueming YuanScience and Technology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Carlos Alberto BandeiraNational Malaria Control Programme, São Tomé and Príncipe, Guangzhou, China.
D'almeida Herodes RompãoNational Malaria Control Programme, São Tomé and Príncipe, Guangzhou, China.
Qin XuArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jianping SongArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Qi WangArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria, one of the most serious parasitic diseases, kills thousands of people every year, especially in Africa. São Tomé and Príncipe are known to have stable transmission of malaria. Indoor residual spraying (IRS) of insecticides and long-lasting insecticidal nets (LLIN) are considered as an effective malaria control interventions in these places. The resistance status of

Indexed as

AnophelesMalariaAfricaAnimalsHumansMosquito VectorsMutationSao Tome and Principeace-1RAnopheles gambiaekdrmalariaresistancevector control

Identifiers

PMID34307185
PMCPMC8295031
OpenAlexW3180113367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.